Basel Medical Group Ltd Ordinary Shares (BMGL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Basel Medical Group Ltd O...

    NASDAQ: BMGL · Real-Time Price · USD
    2.06
    0.09 (4.73%)
    At close: Sep 10, 2025, 3:59 PM

    Basel Medical Ltd Ordinary Shares Income Statement

    Financials in SGD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
    Revenue
    		 10.05M 9.7M 10.66M
    Cost of Revenue
    		 2.25M 2.34M 2.18M
    Gross Profit
    		 7.8M 7.36M 8.48M
    Operating Income
    		 2.2M 2M 2.47M
    Interest Income
    		 n/a 295.59K 246.71K
    Pretax Income
    		 2.4M 2.13M 2.39M
    Net Income
    		 2.07M 1.78M 1.98M
    Selling & General & Admin
    		 3.64M 3.27M 4.04M
    Research & Development
    		 n/a n/a n/a
    Other Expenses
    		 1.97M 2.1M 1.96M
    Operating Expenses
    		 5.61M 5.36M 6.01M
    Interest Expense
    		 176.24K 238.6K 320.87K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 7.86M 7.7M 8.18M
    Income Tax Expense
    		 331.76K 348.28K 408.48K
    Shares Outstanding (Basic)
    		 18.75M 18.75M 18.75M
    Shares Outstanding (Diluted)
    		 18.75M 18.75M 18.75M
    EPS (Basic)
    		 0.11 0.10 0.11
    EPS (Diluted)
    		 0.11 0.10 0.11
    EBITDA
    		 3.11M 2.93M 3.28M
    EBIT
    		 2.58M 2.37M 2.71M
    Depreciation & Amortization
    		 528.73K 557.13K 575.92K

    Add to Watchlist